Published in Br J Clin Pharmacol on February 01, 2007
Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol (2009) 2.14
Predicting adverse drug events from personal health messages. AMIA Annu Symp Proc (2011) 1.40
Information about adverse drug reactions reported in children: a qualitative review of empirical studies. Br J Clin Pharmacol (2010) 1.33
Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example. Br J Clin Pharmacol (2009) 1.26
Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysis. Br J Gen Pract (2011) 1.13
What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association. BMC Clin Pharmacol (2011) 1.13
The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol (2011) 1.10
Motives for reporting adverse drug reactions by patient-reporters in the Netherlands. Eur J Clin Pharmacol (2010) 1.07
An evaluation of knowledge, attitude and practice of Indian pharmacists towards adverse drug reaction reporting: A pilot study. Perspect Clin Res (2013) 1.06
Baseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluation. BMC Med Res Methodol (2011) 1.04
Consumers' reports of suspected adverse drug reactions volunteered to a consumer magazine. Br J Clin Pharmacol (2010) 1.02
Medication errors: the role of the patient. Br J Clin Pharmacol (2009) 0.98
Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review. J Med Internet Res (2015) 0.97
Patients views and experiences in online reporting adverse drug reactions: findings of a national pilot study in Japan. Patient Prefer Adherence (2015) 0.97
Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association. BMC Pharmacol Toxicol (2012) 0.95
Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from klang valley in malaysia. Malays J Med Sci (2013) 0.95
Geriatric conditions, medication use, and risk of adverse drug events in a predominantly male, older veteran population. J Am Geriatr Soc (2011) 0.92
Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system. Eur J Clin Pharmacol (2007) 0.92
Designing adverse event forms for real-world reporting: participatory research in Uganda. PLoS One (2012) 0.90
Perceived adverse drug reactions among non-institutionalized children and adolescents in Germany. Br J Clin Pharmacol (2010) 0.86
The value of patient reporting to the pharmacovigilance system: a systematic review. Br J Clin Pharmacol (2016) 0.86
Consumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFI. Hum Vaccin Immunother (2014) 0.85
Adverse drug reactions--no farewell to harms. Br J Clin Pharmacol (2007) 0.85
What can we learn from parents about enhancing participation in pharmacovigilance? Br J Clin Pharmacol (2013) 0.84
Pharmacovigilance Knowledge among Patients at a Teaching Hospital in Lalitpur District, Nepal. J Clin Diagn Res (2014) 0.83
A plea for a more epidemiological and patient-oriented pharmacovigilance. Eur J Clin Pharmacol (2011) 0.82
Need for involving consumers in Nepal's pharmacovigilance system. Australas Med J (2014) 0.81
Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study. Health Qual Life Outcomes (2014) 0.81
Views of healthcare professionals to linkage of routinely collected healthcare data: a systematic literature review. J Am Med Inform Assoc (2013) 0.81
Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre? Eur J Clin Pharmacol (2017) 0.80
'The more you link, the more you risk …' - a focus group study exploring views about data linkage for pharmacovigilance. Br J Clin Pharmacol (2014) 0.80
Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011. BMC Pharmacol Toxicol (2013) 0.79
Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US. Pharmaceut Med (2015) 0.79
PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs. Pharm Pract (Granada) (2014) 0.79
Adverse drug reactions: analysis of spontaneous reporting system in Europe in 2007-2009. Eur J Clin Pharmacol (2012) 0.77
Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting. Eur J Clin Pharmacol (2015) 0.77
Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance. Int J Obes (Lond) (2016) 0.76
An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy. JMIR Public Health Surveill (2016) 0.76
Medication monitoring in a nurse-led respiratory outpatient clinic: pragmatic randomised trial of the West Wales Adverse Drug Reaction Profile. PLoS One (2014) 0.76
Patient Participation and the Use of Ehealth Tools for Pharmacoviligance. Front Pharmacol (2016) 0.75
Analysis of Patient Narratives in Disease Blogs on the Internet: An Exploratory Study of Social Pharmacovigilance. JMIR Public Health Surveill (2017) 0.75
A Review of Pharmacovigilance. West Indian Med J (2015) 0.75
Adverse drug reactions (ADRS) reporting: awareness and reasons of under-reporting among health care professionals, a challenge for pharmacists. Springerplus (2016) 0.75
Consumer Narratives in ADR Reporting: An Important Aspect of Public Health? Experiences from Reports to a Swedish Consumer Organization. Front Public Health (2015) 0.75
Side effects of antineoplastic and immunomodulating medications reported by European consumers. J Res Pharm Pract (2013) 0.75
Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study. Drug Saf (2016) 0.75
Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study-study protocol. Springerplus (2016) 0.75
Profile of rheumatology patients willing to report adverse drug reactions: bias from selective reporting. Patient Prefer Adherence (2016) 0.75
Knowledge, practice and approaches of health professionals to adverse events following immunization and their reporting in Albania. Heliyon (2017) 0.75
[The importance of patient perspective in drug surveillance systems]. Z Rheumatol (2010) 0.75
Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana. Drug Saf (2017) 0.75
[Pain as adverse drug reaction]. Wien Med Wochenschr (2012) 0.75
A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther (1981) 69.83
Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA (1998) 32.05
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ (2004) 21.39
Antidepressants and adverse effects in young patients: uncovering the evidence. CMAJ (2004) 1.57
Consumer adverse drug reaction reporting: a new step in pharmacovigilance? Drug Saf (2003) 1.50
Patients as a direct source of information on adverse drug reactions. BMJ (1988) 1.42
Reporting adverse drug reactions on a geriatric ward: a pilot project. Eur J Clin Pharmacol (2003) 1.36
Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol (2002) 1.32
Patients' role in reporting adverse drug reactions. Expert Opin Drug Saf (2004) 1.28
[Direct reporting of side effects by the patient: favourable experience in the first year]. Ned Tijdschr Geneeskd (2005) 1.24
Patient reporting of adverse drug reactions: useful information for pain management? Eur J Pain (2003) 1.08
Managing adverse drug reactions: time to get serious. Med J Aust (2005) 1.01
Improving adverse-drug-reaction reporting in ambulatory care clinics at a Veterans Affairs hospital. Am J Health Syst Pharm (2002) 1.00
Consumer groups look to improve adverse event reporting systems. J Natl Cancer Inst (2005) 0.92
The sequence of the human genome. Science (2001) 101.55
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol (2001) 8.25
Sequence and genomic organization of Norwalk virus. Virology (1993) 6.25
The 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors. Anaesthesia (2014) 4.07
Appropriateness of the decision to transfer nursing facility residents to the hospital. J Am Geriatr Soc (2000) 3.99
The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J Biol Chem (2001) 3.64
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol (1998) 3.32
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ (2007) 3.26
Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. J Immunol (1998) 3.03
Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. J Immunol (1999) 2.94
PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J Biol Chem (1994) 2.92
Comprehensive clinical drug information service: first year's experience. Br Med J (1977) 2.77
Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity (1999) 2.67
The topography of awareness: a classification of intra-operative cognitive states. Anaesthesia (2012) 2.61
Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J Virol (1990) 2.45
Are nonspecific practice guidelines potentially harmful? A randomized comparison of the effect of nonspecific versus specific guidelines on physician decision making. Health Serv Res (2000) 2.45
Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies. J Virol (2001) 2.42
Interplay of electron-lattice interactions and superconductivity in superconductivity in Bi2Sr2CaCu2O8+delta. Nature (2006) 2.40
Establishment, maintenance and description of cell lines from the tick Ixodes scapularis. J Parasitol (1994) 2.36
In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjug Chem (2000) 2.30
Crystal structures of medium-chain acyl-CoA dehydrogenase from pig liver mitochondria with and without substrate. Proc Natl Acad Sci U S A (1993) 2.29
Retrieval of water-leaving radiance and aerosol optical thickness over the oceans with SeaWiFS: a preliminary algorithm. Appl Opt (1994) 2.28
Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia. AIDS (2000) 2.26
Error-free and error-prone lesion bypass by human DNA polymerase kappa in vitro. Nucleic Acids Res (2000) 2.25
Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol (2000) 2.18
Fractal model of ion-channel kinetics. Biochim Biophys Acta (1987) 2.17
Changing patterns of self-poisoning in a UK health district. QJM (1996) 2.13
Specificity of DNA lesion bypass by the yeast DNA polymerase eta. J Biol Chem (2000) 2.12
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc Natl Acad Sci U S A (1997) 2.11
FIN219, an auxin-regulated gene, defines a link between phytochrome A and the downstream regulator COP1 in light control of Arabidopsis development. Genes Dev (2000) 2.11
DNA-binding properties of Arabidopsis MADS domain homeotic proteins APETALA1, APETALA3, PISTILLATA and AGAMOUS. Nucleic Acids Res (1996) 2.06
Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res (1997) 2.05
IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases. J Immunol (1995) 2.02
Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes. Circ Res (1991) 1.98
Factors affecting warfarin requirements. A prospective population study. Eur J Clin Pharmacol (1979) 1.95
Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem (1996) 1.92
Characterization of a new avian-like influenza A virus from horses in China. Virology (1992) 1.90
Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1. J Virol (1998) 1.87
The 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: patient experiences, human factors, sedation, consent and medicolegal issues. Anaesthesia (2014) 1.85
Fourteen-year follow-up of children with and without speech/language impairments: speech/language stability and outcomes. J Speech Lang Hear Res (1999) 1.84
Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study. Leukemia (2013) 1.84
Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science (2004) 1.83
Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J (Clin Res Ed) (1984) 1.83
Dominant negative guard cell K+ channel mutants reduce inward-rectifying K+ currents and light-induced stomatal opening in arabidopsis. Plant Physiol (2001) 1.82
Clinical pharmacokinetics of propranolol. Clin Pharmacokinet (1979) 1.81
Isolation of influenza C virus from pigs and experimental infection of pigs with influenza C virus. J Gen Virol (1983) 1.81
Anticoagulants in venous thromboembolism. BMJ (1988) 1.77
Current burden and probable increasing incidence of ESRD in China. Clin Nephrol (2010) 1.74
Lidocaine plasma protein binding. Clin Pharmacol Ther (1980) 1.74
Biomarkers of environmental tobacco smoke in preschool children and their mothers. J Natl Cancer Inst (1994) 1.72
Synaptic connections from large muscle afferents to the motoneurons of various leg muscles in man. Exp Brain Res (1984) 1.71
Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci U S A (1996) 1.70
Adenosine stimulates respiration in man. Br J Clin Pharmacol (1985) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat Biotechnol (1997) 1.66
The tricornered gene, which is required for the integrity of epidermal cell extensions, encodes the Drosophila nuclear DBF2-related kinase. Genetics (2000) 1.65
Safety of late acetylcysteine treatment in paracetamol poisoning. Hum Exp Toxicol (1990) 1.65
2,2-Diphenyl-1-picrylhydrazyl radical-scavenging active components from Polygonum multiflorum thunb. J Agric Food Chem (1999) 1.64
Random and systematic medication errors in routine clinical practice: a multicentre study of infusions, using acetylcysteine as an example. Br J Clin Pharmacol (2001) 1.63
Rational modification of protein stability by the mutation of charged surface residues. Biochemistry (2000) 1.62
Predicting patients' warfarin requirements. Lancet (1977) 1.61
Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift. Am J Surg Pathol (1999) 1.61
Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart (2002) 1.58
Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis (1995) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Spinocerebellar ataxia: localization of an autosomal dominant locus between two markers on human chromosome 6. Am J Hum Genet (1987) 1.55
Phosphate enemas in childhood: cause for concern. BMJ (1991) 1.55
Serum proteomic profiling in patients with drug-induced liver injury. Aliment Pharmacol Ther (2012) 1.55
Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res (1983) 1.55
Nasal challenge with diesel exhaust particles can induce sensitization to a neoallergen in the human mucosa. J Allergy Clin Immunol (1999) 1.54
Absence of memory for intraoperative information during surgery under adequate general anaesthesia. Br J Anaesth (1997) 1.51
Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res (1996) 1.51
Quantitative DNA fiber mapping. Hum Mol Genet (1995) 1.50
Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis. Kidney Int (2006) 1.50
Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. J Pathol (2007) 1.50
Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med (1996) 1.49
The plasma protein binding of basic drugs. Br J Clin Pharmacol (1986) 1.49
Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis. Br J Dermatol (2015) 1.49
Improved GFR estimation by combined creatinine and cystatin C measurements. Kidney Int (2007) 1.48
Acute effects of thirty minutes of light-intensity, intermittent exercise on patients with chronic fatigue syndrome. Phys Ther (1999) 1.48
The clinical value of rapid assay for plasma B-type natriuretic peptide in differentiating congestive heart failure from pulmonary causes of dyspnoea. Int J Clin Pract (2007) 1.46
A clinical rating scale for Batten disease: reliable and relevant for clinical trials. Neurology (2005) 1.45
Notch3 signaling initiates choroid plexus tumor formation. Oncogene (2006) 1.43
Atropine as possible contaminant of comfrey tea. Lancet (1989) 1.43
Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J Immunol (1996) 1.43
Association of adiponectin multimers with Barrett's oesophagus. Gut (2009) 1.43
Espin contains an additional actin-binding site in its N terminus and is a major actin-bundling protein of the Sertoli cell-spermatid ectoplasmic specialization junctional plaque. Mol Biol Cell (1999) 1.42
Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia (2004) 1.40
The role of hyaluronan in tumour neovascularization (review). Int J Cancer (1995) 1.40
Community exposures to chemical incidents: development and evaluation of the first environmental public health surveillance system in europe. J Epidemiol Community Health (2000) 1.39
Absence of memory for intra-operative information during surgery with total intravenous anaesthesia. Br J Anaesth (2001) 1.39
Objective sleepiness measures in pediatric obstructive sleep apnea. Pediatrics (2001) 1.39
Artificial neural network to assist psychiatric diagnosis. Br J Psychiatry (1996) 1.39
Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue. Cancer Res (1993) 1.39
The effect of intravenous aminophylline on essential tremor. Br J Clin Pharmacol (1997) 1.38
Reverse transcriptase polymerase chain reaction on fine needle aspirates for rapid detection of translocations in synovial sarcoma. Acta Cytol (1998) 1.38
P1148A in fibrillin-1 is not a mutation anymore. Nat Genet (1997) 1.37